4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000139
Director acquired 6,037 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2025-06-03 | Grant or award | +6,037 | 31,794 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2025-06-03 | Grant or award · Stock Option (right to buy) | +18,111 | 18,111 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1749155311.xml…